Skip to main content
Fig. 4 | Journal of Nanobiotechnology

Fig. 4

From: Dual activity of PD-L1 targeted Doxorubicin immunoliposomes promoted an enhanced efficacy of the antitumor immune response in melanoma murine model

Fig. 4

Pharmacokinetics evaluation. The average of plasma concentrations (n = 3 mice) per time point is represented by symbols together with the mean standard deviation. Lines correspond to the interpolation data. Data were collected from B16OVA tumor bearing mice treated with a single intravenous dose (3 mg/kg) of free Dox, Conventional Dox liposomes (LDP) and Targeted Dox liposomes or immunoliposomes (LPF)

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us